Form 13-F position report

CERO THERAPEUTICS HLDGS INC

Reported by Avantax Planning Partners Inc

PBAX CUSIP 71902K105 Manager CIK 0001005441

First reported at 80,000 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q2 2024
Shares 80,000 Quarter-end amount reported
Reported value $23,920 Fair value at quarter end
Consecutive quarters held 1 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-06-30 23920
2024-09-30 126993
2024-12-31 155109
2025-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for CERO THERAPEUTICS HLDGS INC held by Avantax Planning Partners Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2025 Reduced 0 -2,585,151 (-100.0%) 0 $0 2025-04-29
Q4 2024 Added 2,585,151 +1,224,021 (89.9%) < 0.01% $155,109 2025-02-07
Q3 2024 Added 1,361,130 +1,281,130 (1601.4%) < 0.01% $126,993 2024-11-14
Q2 2024 New 80,000 +80,000 (0.0%) < 0.01% $23,920 2024-08-09

Who else reported the position

18 managers reported CERO THERAPEUTICS HLDGS INC for Q2 2024.

Managers reporting CERO THERAPEUTICS HLDGS INC in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ARCH Venture Management LLC Unchanged 1,444,296 0 0.16% $431,845 2 qtrs
Arena Investors LP New 198,566 +198,566 0.47% $59,371 1 qtr
Avantax Planning Partners Inc This report New 80,000 +80,000 < 0.01% $23,920 1 qtr
GEODE CAPITAL MANAGEMENT LLC Added 48,142 +37,554 < 0.01% $14,394 8 qtrs
JANE STREET GROUP LLC Added 32,037 +5,522 < 0.01% $9,579 2 qtrs
TWO SIGMA INVESTMENTS LP New 18,096 +18,096 < 0.01% $5,411 1 qtr
CI Private Wealth LLC New 14,999 +14,999 < 0.01% $4,485 1 qtr
Birchview Capital LP Unchanged 12,972 0 < 0.01% $3,879 2 qtrs
HRT FINANCIAL LP New 11,935 +11,935 < 0.01% $3,000 1 qtr
ADVISOR GROUP HOLDINGS INC New 400 +400 < 0.01% $120 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 09, 2024
Filing type
13F-HR
Position type
CLASS A COM

Voting authority reported

Sole
0
Shared
0
None
80,000

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.